JOP20200323A1 - طرق لتصنيع تركيبات الأحماض الأمينية - Google Patents

طرق لتصنيع تركيبات الأحماض الأمينية

Info

Publication number
JOP20200323A1
JOP20200323A1 JOP/2020/0323A JOP20200323A JOP20200323A1 JO P20200323 A1 JOP20200323 A1 JO P20200323A1 JO P20200323 A JOP20200323 A JO P20200323A JO P20200323 A1 JOP20200323 A1 JO P20200323A1
Authority
JO
Jordan
Prior art keywords
methods
amino acid
acid compositions
manufacturing amino
manufacturing
Prior art date
Application number
JOP/2020/0323A
Other languages
English (en)
Inventor
Andrew M Wood
Thomas Hanlon
Ralph Yamamoto
Daniel Rothenberg
Denise K Kwok
Original Assignee
Axcella Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Axcella Health Inc filed Critical Axcella Health Inc
Publication of JOP20200323A1 publication Critical patent/JOP20200323A1/ar

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

يوفر الكشف الحالي طرق لتصنيع مستحضرات ممزوجة واسعة النطاق تشتمل على واحد أو أكثر من الأحماض الأمينية حيث يكون للمستحضرات خواص معينة.
JOP/2020/0323A 2018-06-20 2019-06-19 طرق لتصنيع تركيبات الأحماض الأمينية JOP20200323A1 (ar)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862687725P 2018-06-20 2018-06-20

Publications (1)

Publication Number Publication Date
JOP20200323A1 true JOP20200323A1 (ar) 2020-12-14

Family

ID=67226342

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2020/0323A JOP20200323A1 (ar) 2018-06-20 2019-06-19 طرق لتصنيع تركيبات الأحماض الأمينية

Country Status (17)

Country Link
US (1) US11679089B2 (ar)
EP (1) EP3810168A1 (ar)
JP (1) JP2021529735A (ar)
KR (1) KR20210023846A (ar)
CN (1) CN112823018A (ar)
AR (1) AR115581A1 (ar)
AU (1) AU2019288371A1 (ar)
BR (1) BR112020025831A2 (ar)
CA (1) CA3099762A1 (ar)
CL (1) CL2020003277A1 (ar)
IL (1) IL279328A (ar)
JO (1) JOP20200323A1 (ar)
MA (1) MA52957A (ar)
MX (1) MX2020013732A (ar)
SG (1) SG11202011611XA (ar)
TW (1) TW202015668A (ar)
WO (1) WO2019246201A1 (ar)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2018201024A1 (en) 2017-04-28 2018-11-01 Axcella Health Inc. Amino acid compositions and their use for the treatment of traumatic brain injury
MX2020001765A (es) 2017-08-14 2020-07-29 Axcella Health Inc Composiciones de aminoacidos para el tratamiento de enfermedad hepatica.
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法
JP2021529735A (ja) 2018-06-20 2021-11-04 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． アミノ酸組成物の製造方法
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
WO2023009444A1 (en) 2021-07-26 2023-02-02 Axcella Health Inc. Amino acid compositions and methods for use in the treatment of post-acute sequelae of covid-19
NL2038264B1 (en) * 2024-07-18 2025-03-06 West China Hospital Sichuan Univ Compound nutritional preparation for reducing fat and increasing muscle and preparation method thereof

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
DE69331528T2 (de) 1992-12-23 2002-10-31 Abbott Laboratories, Abbott Park Medizinische nahrungsmittel für die ernährungsergänzung bei metabolischen erkrankungen von säuglingen/kleinkindern
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
EP0891719A1 (en) 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
US20010041187A1 (en) 1998-10-20 2001-11-15 Carl W Hastings Performance-enhancing dietary supplement
JP4108605B2 (ja) * 2001-11-13 2008-06-25 協和醗酵工業株式会社 アミノ酸含有口腔内速崩壊錠及びその製造方法
WO2004092202A1 (en) * 2003-04-07 2004-10-28 Novetide, Ltd. Process for production of cyclic peptides
US20040213838A1 (en) 2003-04-24 2004-10-28 Mazer Terrence B. Medical food tablets containing free amino acids
US20070141150A1 (en) 2003-12-30 2007-06-21 Raghupathi Kandarapu Pharmaceutical composition
US20060073254A1 (en) 2004-10-04 2006-04-06 Steve Catani No-carb tabletop sweeteners substitute
EP1839502A4 (en) 2004-12-07 2010-03-24 Ajinomoto Kk FINE AMINO ACID POWDER AND SUSPENSION THEREOF
US20070286909A1 (en) * 2006-06-07 2007-12-13 Daniel S. Smith Amino acid compositions
WO2011043647A1 (en) * 2009-10-09 2011-04-14 N.V. Nutricia Amino acid composition with improved dispersibility
JP2012136492A (ja) 2010-12-25 2012-07-19 Shiga Prefecture Seiyaku Kk 服用感を改善された漢方内服液剤
WO2015002527A1 (en) * 2013-07-05 2015-01-08 N.V. Nutricia Amino acid composition for use in the treatment of a pdd
EP3027181A1 (en) 2013-07-31 2016-06-08 Leeds Beckett University Dietary supplement
RU2016110800A (ru) 2013-09-25 2017-10-30 Пронутриа Биосайенсис, Инк. Составы и композиции для поддержания и увеличения мышечной массы, силы и результативности, и способы их производства и использования
US20180125926A1 (en) 2013-09-25 2018-05-10 Axcella Health Inc. Compositions and Formulations and Methods of Production and Use Thereof
FR3032883B1 (fr) 2015-02-24 2017-03-17 International Nutrition Res Company Composition pour la prevention et le traitement de la steatose et de la steatohepatite metaboliques
JO3543B1 (ar) * 2015-09-28 2020-07-05 Applied Pharma Res تراكيب حمض أميني إصدار معدل تعطى عن طريق الفم
EP4098282A1 (en) * 2016-02-04 2022-12-07 Czap Research And Development, LLC Controlled-release and stratified cyclodextrin inclusion complex vehicles
PL238958B1 (pl) 2016-06-29 2021-10-25 Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym
US20180015122A1 (en) 2016-07-14 2018-01-18 Companion Supplements, LLC Pharmaceutical composition effective in preventing adverse effects associated with the use of glucocorticoids
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JOP20190147A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات
JP2018154598A (ja) 2017-03-21 2018-10-04 株式会社明治 アミノ酸含有顆粒およびその製造方法
WO2018201024A1 (en) 2017-04-28 2018-11-01 Axcella Health Inc. Amino acid compositions and their use for the treatment of traumatic brain injury
JP7370960B2 (ja) 2017-08-14 2023-10-30 アクセラ・ヘルス・インコーポレイテッド 神経細胞損傷の治療のためのアミノ酸組成物
MX2020001765A (es) 2017-08-14 2020-07-29 Axcella Health Inc Composiciones de aminoacidos para el tratamiento de enfermedad hepatica.
EP3810276A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the reduction or treatment of inflammation
CU20200106A7 (es) 2018-06-20 2021-08-06 Axcella Health Inc Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
JP2021529735A (ja) 2018-06-20 2021-11-04 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． アミノ酸組成物の製造方法
WO2019246221A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the treatment of liver diseases and disorders
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法
US20210275480A1 (en) 2018-06-20 2021-09-09 Axcella Health Inc. Compositions and methods for the reduction or treatment of fibrosis
WO2019246299A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the reduction or treatment of insulin resistance and metabolic conditions
MX2020013731A (es) 2018-06-20 2021-02-26 Axcella Health Inc Composiciones para terapia y salud que contienen aminoacidos con sabor amargo.

Also Published As

Publication number Publication date
CL2020003277A1 (es) 2021-07-09
SG11202011611XA (en) 2021-01-28
BR112020025831A2 (pt) 2021-03-23
CA3099762A1 (en) 2019-12-26
AR115581A1 (es) 2021-02-03
US20190388374A1 (en) 2019-12-26
JP2021529735A (ja) 2021-11-04
US11679089B2 (en) 2023-06-20
MX2020013732A (es) 2021-02-26
KR20210023846A (ko) 2021-03-04
EP3810168A1 (en) 2021-04-28
WO2019246201A1 (en) 2019-12-26
TW202015668A (zh) 2020-05-01
MA52957A (fr) 2021-04-28
CN112823018A (zh) 2021-05-18
AU2019288371A1 (en) 2020-12-03
IL279328A (en) 2021-01-31

Similar Documents

Publication Publication Date Title
JOP20200323A1 (ar) طرق لتصنيع تركيبات الأحماض الأمينية
MX2021014863A (es) Composiciones de proteina anti-vegf y metodos para producir la misma.
CY1124806T1 (el) Αντισωματα enanti-cd40 και χρησεις αυτων
EA202090090A1 (ru) Включение неприродных нуклеотидов и способы с ними
EA201992019A1 (ru) Съедобные и биоразлагаемые столовые приборы
EA201890749A1 (ru) ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ (ACC) И ИХ ПРИМЕНЕНИЕ
MX383537B (es) Mutantes de proteína f de rsv.
TN2018000276A1 (en) Inhibitors of receptor-interacting protein kinase 1.
MX381487B (es) Ciertos inhibidores de la proteina quinasa.
EA201691794A1 (ru) Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
MX2018010983A (es) Derivado de 3-desoxi y composiciones farmaceuticas del mismo.
MX385972B (es) Partículas y composiciones de nicotina.
EA201890815A1 (ru) Аминокислотные композиции с модифицированным высвобождением для перорального введения
EA202092692A1 (ru) Аналоги рапамицина и их применения
EA201692548A1 (ru) Минеральные аминокислотные комплексы активных веществ
MX2022007275A (es) Composiciones de acidos biliares y compuestos de fenilbutirato.
MX2018010801A (es) Derivados de acido a-truxilico y composiciones farmaceuticas de los mismos.
CL2021001689A1 (es) Ácido r-piridiloxicarboxílico y sal, derivado del éster, método de preparación, composición herbicida y aplicación del mismo.
MX2022003879A (es) Proceso para elaborar acidos alcansulfonicos.
EA201890799A1 (ru) Производные азетидина для визуализации тау-белка
MX2021015879A (es) Peptidos restringidos.
JOP20200066B1 (ar) طريقة لتحضير أحماض ألفا هالو ألكانويك لا تماثلية
DK3989999T3 (da) Ny sammensætning indeholdende forgrenede aminosyrer
HK40050980A (en) Methods of manufacturing amino acid compositions